about
Rapid pharmacokinetic and biodistribution studies using cholorotoxin-conjugated iron oxide nanoparticles: a novel non-radioactive methodTumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer fociApproach to Rapid Synthesis and Functionalization of Iron Oxide Nanoparticles for High Gene Transfection.Assessing the barriers to image-guided drug delivery.Preparation of porous hydroxyapatite scaffolds by combination of the gel-casting and polymer sponge methods.A simple and highly sensitive method for magnetic nanoparticle quantitation using 1H-NMR spectroscopyCCL21 and IFNγ recruit and activate tumor specific T cells in 3D scaffold model of breast cancer.PEG-mediated synthesis of highly dispersive multifunctional superparamagnetic nanoparticles: their physicochemical properties and function in vivoResponse characteristics of single-cell impedance sensors employed with surface-modified microelectrodesChitosan-based thermoreversible hydrogel as an in vitro tumor microenvironment for testing breast cancer therapies.Functionalized nanoparticles with long-term stability in biological media.Multifunctional Magnetic Nanoparticles for Medical Imaging Applications.Glypican-3-targeted 89Zr PET imaging of hepatocellular carcinoma.Proliferation and enrichment of CD133(+) glioblastoma cancer stem cells on 3D chitosan-alginate scaffolds.Superparamagnetic iron oxide nanoparticle-based delivery systems for biotherapeuticsChitosan-alginate hybrid scaffolds for bone tissue engineering.Redox-responsive magnetic nanoparticle for targeted convection-enhanced delivery of O6-benzylguanine to brain tumorsThermoreversible poly(ethylene glycol)-g-chitosan hydrogel as a therapeutic T lymphocyte depot for localized glioblastoma immunotherapy.Glypican-3-targeting F(ab')2 for 89Zr PET of hepatocellular carcinoma.Glypican-3 targeting of liver cancer cells using multifunctional nanoparticlesIL-6 promotes prostate tumorigenesis and progression through autocrine cross-activation of IGF-IR.Cancer cell invasion: treatment and monitoring opportunities in nanomedicine.Single-cell bioelectrical impedance platform for monitoring cellular response to drug treatment.Short peptides enhance single cell adhesion and viability on microarrays.Cellular impedance biosensors for drug screening and toxin detection.Stable and efficient Paclitaxel nanoparticles for targeted glioblastoma therapyAnti-HER2/neu peptide-conjugated iron oxide nanoparticles for targeted delivery of paclitaxel to breast cancer cells.Nanoparticle-Mediated Target Delivery of TRAIL as Gene Therapy for GlioblastomaInfluence of cell adhesion and spreading on impedance characteristics of cell-based sensorsHexanoyl-Chitosan-PEG Copolymer Coated Iron Oxide Nanoparticles for Hydrophobic Drug Delivery.Modeling the tumor microenvironment using chitosan-alginate scaffolds to control the stem-like state of glioblastoma cells.Iron-Oxide-Based Nanovector for Tumor Targeted siRNA Delivery in an Orthotopic Hepatocellular Carcinoma Xenograft Mouse Model3D Porous Chitosan-Alginate Scaffolds as an In Vitro Model for Evaluating Nanoparticle-Mediated Tumor Targeting and Gene Delivery to Prostate Cancer.Integrated bi-layered scaffold for osteochondral tissue engineering.High-throughput and high-yield fabrication of uniaxially-aligned chitosan-based nanofibers by centrifugal electrospinning.Magnetic nanoparticles in MR imaging and drug delivery.In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes.Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging.Polyblend nanofibers for biomedical applications: perspectives and challenges.Surface engineering of iron oxide nanoparticles for targeted cancer therapy.
P50
Q27333732-33B86451-0127-493A-8A27-7E3CA7D0F5D2Q28237061-19CD4B63-8CBE-4D4E-BB04-82186BCB467BQ30360860-A557FCFF-60A4-4099-BC2B-50D1841B9D01Q30422169-28E4D924-A193-4652-BB12-C48F0BB39898Q30936683-C814F41E-DC5B-4CAE-9398-87DDE8FC5622Q33514560-4C895583-E381-4C2B-979F-37F301578F38Q33726546-1B34CE0C-6305-4B37-9492-EA53A3D03A0CQ33815847-6AA18F44-ABD5-42E5-9A79-49A266258F0BQ33821321-564DA98A-EE07-44D8-9033-CCC9254279C7Q33894643-AFD713DD-0FD5-4B7C-B218-2D083E3976CDQ33903311-A2D2059C-632E-4933-BE9B-F5BFD7E6AA98Q33946006-C512D1B0-5F66-4591-BEC4-AA06089EDCCAQ33974776-D4008827-DEF2-4ADE-A6F3-13491497EFFBQ34205351-2BC2B633-C2FA-4D53-8037-BAEBFFBEFAB4Q34205366-B0B0B78F-4438-4D24-9E8C-7208913EF76BQ34380657-DE34A6B3-89AE-4EAE-9C5F-05ACE7852E34Q34419939-BC927DE6-76FC-44F1-AF1A-A88BBE3C03CEQ34434111-730B187E-9837-40E9-BBEA-2F5DE85E737FQ34657257-989531EE-EB00-4F53-AD79-DC9C5E4D633AQ34675546-7A277320-8640-4C72-BE2B-FAC2B0C7F9CAQ35037290-4413A01F-26A9-4551-9AE0-960EF925FF3BQ35093966-C9D8C66C-7D7B-4027-8F0D-D93DAF814B71Q35228555-142F77CD-3051-46EB-87F6-3FBC87DBC593Q35487904-EB729849-4A58-4B5E-AF6B-E0DC629D7F64Q35487937-31137A81-E2CF-4ED9-AE03-BD78AC949F26Q35575328-C2776AA8-30DE-48B0-BD35-28E66C3D3E7BQ36381340-C03B53CB-1064-477D-8A49-0B1CC30CF2AAQ36470507-32DE8BDD-6168-49F0-858E-6DDC805C83A9Q36539438-8B3E0CB9-A970-477B-A58A-539355022B46Q36584869-939733D4-CE67-446C-979E-5AB49AA48FDAQ36717318-D453784B-4CDB-42A1-99FB-F0FD31E161E5Q36792563-FF1643CC-2B1A-42C3-AE99-BF1E62E840ACQ36798100-7B1361ED-D8DC-429D-B821-70A23D05009EQ36816496-AD8D660B-0D64-4E71-B293-68886F232923Q36867073-B268E2DB-9CBB-4282-80F0-40BD5A480C09Q37192908-EAED14F6-F6E8-402C-8B6A-71CA3970755FQ37216626-4E6BFA27-EFA3-473C-AACD-94A1B22EF005Q37631874-2671FFC5-2E96-40F5-9050-C293CD40BCEAQ37684080-8B68870B-CF89-4E01-BCD7-886B7D394018Q37870178-2BB8485D-C6E2-4C01-9684-8D6654CFF75F
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Miqin Zhang
@ast
Miqin Zhang
@en
Miqin Zhang
@es
Miqin Zhang
@sl
type
label
Miqin Zhang
@ast
Miqin Zhang
@en
Miqin Zhang
@es
Miqin Zhang
@sl
altLabel
张米琴
@en
prefLabel
Miqin Zhang
@ast
Miqin Zhang
@en
Miqin Zhang
@es
Miqin Zhang
@sl
P106
P1153
7601553864
P31
P496
0000-0001-8974-1494